Alerts will be sent to your verified email
Verify Email
UNICK
|
Unick Fix-A-Form
|
Chandra Bhagat Pharm
|
Lasa Supergenerics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
9.15 % | 2.7 % | -8.32 % |
|
5yr Avg Net Profit Margin
|
4.16 % | 0.58 % | -8.22 % |
|
Price to Book
|
1.14 | 0.0 | 0.5 |
|
P/E
|
14.93 | 47.94 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
21.15 Days | 56.06 Days | 11.27 Days |
|
5yr Average Interest Coverage Ratio
|
2.62 | 1.54 | -18.91 |
|
5yr Avg ROCE
|
12.8 % | 10.71 % | 1.03 % |
|
5yr Avg Operating Profit Margin
|
14.14 % | 2.17 % | 9.99 % |
|
5 yr average Debt to Equity
|
0.86 | 0.85 | 0.2 |
|
5yr CAGR Net Profit
|
-7.47 % | 37.62 % | n/a |
|
5yr Average Return on Assets
|
3.64 % | 0.95 % | -5.59 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.57 % | 71.2 % | 53.65 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 20.66 % |
|
Change in Promoter Holding (3 Yrs)
|
35.92 % | 0.78 % | 9.87 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Unick Fix-A-Form
|
Chandra Bhagat Pharm
|
Lasa Supergenerics
|
|---|